Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 28, 2020

SELL
$0.75 - $2.55 $7,500 - $25,500
-10,000 Closed
0 $0
Q3 2019

Oct 17, 2019

SELL
$1.48 - $2.52 $14,800 - $25,200
-10,000 Reduced 50.0%
10,000 $17,000
Q2 2018

Aug 03, 2018

BUY
$1.89 - $4.95 $37,800 - $99,000
20,000 New
20,000 $79,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $356M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Baskin Financial Services Inc. Portfolio

Follow Baskin Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baskin Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baskin Financial Services Inc. with notifications on news.